Leonard Calabrese, DO, and Edward Li, PharmD, MPH, BCOP, discuss how to interpret the efficacy and safety data for biosimilar products, and the implications of biosimilars for clinical practice.
Watch the presentation at your own pace.
Download slides to your library.
Read the activity transcript.
Rheumatologists, oncologists, dermatologists, gastroenterologists, nephrologists, pharmacists, and other clinicians who currently use or may consider using biosimilars in clinical practice.
1.00 AMA PRA Category 1 Credit™.
1.00 ACPE Contact Hour
|Opens:||May 26, 2017|
|Expires:||May 25, 2018|
Other Health Care Providers